This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Kinex Pharmaceuticals, LLC, Athenex, Inc.. Active years: 2010-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2019
Title: Innovations and Contributions of Jeremy A Cody
Introduction
Jeremy A Cody is a notable inventor based in Clifton Springs, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of compositions for modulating kinase cascades. With a total of 8 patents to his name, Cody's work has implications for various therapeutic applications.
Latest Patents
Cody's latest patents include innovative compositions that comprise 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide and its mesylate and dihydrochloride salts. These inventions provide an efficient process for synthesizing these compounds and methods for modulating components of a kinase cascade. Additionally, he has developed a novel polymorph of the mesylate salt characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, showcasing a distinct crystalline structure.
Career Highlights
Throughout his career, Jeremy A Cody has worked with prominent companies in the pharmaceutical industry, including Kinex Pharmaceuticals, LLC and Athenex, Inc. His experience in these organizations has allowed him to contribute to cutting-edge research and development in drug formulation and delivery.
Collaborations
Cody has collaborated with esteemed colleagues such as David G Hangauer, Jr and Debasis Patra. These partnerships have further enhanced his research capabilities and innovation potential.
Conclusion
Jeremy A Cody's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in therapeutic applications and drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
